Get the Stockscreener App
5.99
5.36%
0.305
After Hours:
5.98
-0.010
-0.17%
Embecta Corp stock is traded at $5.99, with a volume of 1.05M.
It is up +5.36% in the last 24 hours and up +21.26% over the past month.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
See More
Previous Close:
$5.685
Open:
$5.77
24h Volume:
1.05M
Relative Volume:
0.99
Market Cap:
$339.39M
Revenue:
$1.04B
Net Income/Loss:
$111.90M
P/E Ratio:
3.0405
EPS:
1.9701
Net Cash Flow:
$205.80M
1W Performance:
+1.87%
1M Performance:
+21.26%
6M Performance:
-32.32%
1Y Performance:
-55.23%
1-Day Range:
$5.77
$6.11
1-Week Range:
$5.67
$6.16
52-Week Range:
$2.77
$14.91
Embecta Corp Stock (EMBC) Company Profile
Name
Embecta Corp
Sector
Industry
Phone
(862) 401-0000
Address
300 KIMBALL DRIVE, PARSIPPANY
Compare EMBC vs ISRG, BDX, RMD, MDLN, ALC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
5.99 | 339.39M | 1.04B | 111.90M | 205.80M | 1.9701 |
ISRG
Intuitive Surgical Inc
|
427.64 | 151.08B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
188.89 | 51.45B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
234.60 | 32.99B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.76 | 31.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
64.35 | 31.11B | 10.63B | 819.00M | 1.59B | 1.6577 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-06-26 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-10-25 | Initiated | Mizuho | Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-27-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | Wolfe Research | Peer Perform |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Sep-08-22 | Initiated | BTIG Research | Neutral |
| Aug-01-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-21-22 | Initiated | BofA Securities | Underperform |
View All
Embecta Corp Stock (EMBC) Latest News
EMBECTA CORP. (NASDAQ: EMBC) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Embecta Corp. (EMBC) And Encourages Investors to Connect - ACCESS Newswire
Embecta (EMBC) Institutional Ownership 2026 - marketbeat.com
Embecta director Milton Mayo sells $36,971 in shares By Investing.com - Investing.com Canada
Embecta director Milton Mayo sells $36,971 in shares By Investing.com - Investing.com Australia
Embecta director Milton Mayo sells $36,971 in shares By Investing.com - Investing.com Australia
Embecta director Milton Mayo sells $36,971 in shares - Investing.com
Embecta director Milton Mayo sells $36,971 in shares - Investing.com India
Embecta director Milton Mayo sells $36,971 in shares By Investing.com - Investing.com Nigeria
(EMBC) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Embecta Corp. (EMBC) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Embecta (NASDAQ: EMBC) director files to sell $36,891 in stock - Stock Titan
Embecta Corp. (EMBC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Embecta Corp. (EMBC) Investigation: Bronstein, Gewirtz & Grossman - natlawreview.com
EMBECTA CORP. (NASDAQ: EMBC) SHAREHOLDER INVESTIGATION - GlobeNewswire
Embecta to Participate in Investor Events - marketscreener.com
embecta to Participate in Investor Events - GlobeNewswire
embecta plans meetings with investors in Boston and Nashville - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating Embecta Corp. (EMBC) And Encourages Stockholders to Connect - ACCESS Newswire
EMBECTA CORP. (EMBC) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty - TMX Newsfile
The Bottom Fishing ClubEmbecta: Excellent Turnaround Prospect In Defensive Medical Products - Seeking Alpha
Embecta Corp. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsEMBC - Eastern Progress
$EMBC Notification: Embecta Accused of Misrepresentations about its Insulin Pen Issues in Securities Fraud Class Action - Eastern Progress
EBIT per share of Embecta Corporation – HAM:JX7 - TradingView
Embecta Corporation Balance Sheet – HAM:JX7 - TradingView
Law firm probes Embecta directors for possible breach of fiduciary duty to shareholders - Pluang
EMBECTA CORP. (EMBC) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty - TMX Newsfile
EMBC Stock News: Embecta Sued for Securities Fraud over Alleged Misrepresentations and Corresponding 57% Stock Drop - TradingView
EMBC Stock News: Embecta Sued for Securities Fraud over Alleged Misrepresentations and Corresponding 57% Stock Drop - Morningstar
EMBC Stock News: Embecta Sued for Securities Fraud over Alleged Misrepresentations and Corresponding 57% Stock Drop - PR Newswire
EMBC DEADLINEFINAL REMINDER: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Embecta Corp. to Contact the Firm Today! - ACCESS Newswire
EMBC Deadline: EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit - Morningstar
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities Class Action Lawsuit Deadline on August 17, 2026 - AOL.com
Embecta Investors Face Class Action Deadline - stl.news
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities Class Action Lawsuit Deadline on August 17, 2026 - 巴士的報
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities Class Action Lawsuit Deadline on August 17, 2026 - Bluefield Daily Telegraph
Bronstein, Gewirtz & Grossman LLC Urges Embecta Corp. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with SBS Law - Business Wire
EMBC Court News: Embecta Securities Fraud Class Action - GlobeNewswire
Embecta Corp. Sued for Securities Law ViolationsFINAL DEADLINE TODAYEMBC - TradingView
EMBC DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, - GlobeNewswire
EMBC DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Alerts Embecta Corp. Investors to Participate in the Class Action Lawsuit Today - ACCESS Newswire
Liquidity Mapping Around (EMBC) Price Events - Stock Traders Daily
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities Class Action Lawsuit Deadline on August 17, 2026 - Morningstar
EMBC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities Class Action Lawsuit Deadline on August 17, 2026 - PR Newswire
EMBC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Embecta Corp. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Embecta Corp. (EMBC) Notice of August 17, 2026 Deadline in Class Action Lawsuit – Hagens Berman - globenewswire.com
Kaplan Fox Continues to Remind Embecta Corp. (NASDAQ: EMBC) Investors of the Lead Plaintiff Deadline on August 17, 2026 - Barchart.com
Embecta Corp. (EMBC) Investors: August 17, 2026 Lead Plaintiff Deadline in Class Action LawsuitHagens Berman - Finansavisen
Embecta Corp Stock (EMBC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Embecta Corp Stock (EMBC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Morris Milton Mayo | Director |
Sep 04 '26 |
Proposed Sale |
5.86 |
6,293 |
36,891 |
0 |
| Kurdikar Devdatt | President and CEO |
Aug 12 '26 |
Buy |
4.70 |
30,000 |
140,937 |
804,919 |
| Elguicze Jacob | SVP and CFO |
Aug 12 '26 |
Buy |
4.67 |
20,000 |
93,360 |
309,139 |
| Mann Jeffrey Z | Pres, Pharm Svc&Prod Mgmt, CLO |
Aug 12 '26 |
Buy |
4.99 |
20,000 |
99,800 |
262,915 |
| HOMBACH ROBERT J. | Director |
Aug 12 '26 |
Buy |
4.97 |
45,000 |
223,848 |
109,587 |
0.23%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):